Riskpilot← Back to searchSign inGet full accessOctoax AB
ABActiveOrg 5593128316Aspängsvägen 1Medical specialists activities · NACE 8622Est. 20211 employees
Revenue 2024
SEK 0
EBITDA margin
—
+82% vs 2023
Equity ratio
18.1%
Financial strength
Net profit 2024
SEK -25K
+83% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -26K | +82% |
| Net profit | SEK -25K | +83% |
| Total assets | SEK 186K | -12% |
| Equity | SEK 34K | -43% |
| Employees | 1 | — |
Legal name
Octoax AB
Org number
5593128316
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
19 april 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall erbjuda konsultverksamhet, tjänster och produkter inom hudvård och hudläkarvård samt annan därmed förenlig verksamhet. Bolaget skall även syssla med värdepappers och fastighetsförvaltning.
Address
Aspängsvägen 1
Email
hk-ljo2@outlook.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 968 | 1 014 | 0 | 0 |
| Staff expenses | — | −834 | −66 | −0 |
| EBITDA | 567 | 44 | −142 | −26 |
| Depreciation & amort. | −0 | — | — | — |
| EBIT | 567 | 44 | −142 | −26 |
| Net financials | — | −0 | −2 | 1 |
| Profit before tax | 427 | 33 | −143 | −25 |
| Tax | −88 | −7 | — | — |
| Net profit | 339 | 26 | −143 | −25 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 916 | 968 | 210 | 186 |
| Equity | 364 | 202 | 58 | 34 |
| Long-term debt | 0 | — | — | — |
| Short-term debt | 411 | 614 | 0 | — |
| Total debt | 411 | 614 | — | — |
EBITDA margin
-2614400.0%
This company
15.8%
Market median
-16546935% vs market
20212024
Equity ratio
18.1%
This company
38.2%
Market median
-53% vs market
20212024
Return on equity
-74.4%
This company
18.4%
Market median
-504% vs market
20212024
Net profit margin
-2491200.0%
This company
8.1%
Market median
-30755656% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
4.54×
This company
0.62×
Market median
-632% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-04-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Octoax AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Johan Olauson | Board of Directors | 0 companies |
| Lars Gunnar Olausson | Deputy Board Member | 0 companies |